Indefinite Delivery Contract 36E79725D0048

Award Date 9/6/25
Last Date to Order 9/5/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The National Acquisition Center of the U.S. Department of Veterans Affairs (VA) awarded a single-award Indefinite Delivery Contract (IDC) to Mylan Pharmaceuticals Inc. to provide Loperamide Hydrochloride (HCL) capsules. The contract has a potential value of $8,960,715.85 and a period of performance from July 30, 2020 to July 29, 2025, with four one-year option periods. The contracted products will be distributed through the VA's and Department of Defense's (DoD) respective Pharmaceutical Prime...
The federal contract IDV award is for the delivery of Alvimopan 12mg capsules to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Centers (FHCCs). The one-year base contract with four one-year option periods was awarded to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The ceiling value of the IDV is $3,571,497.30. The...
The federal contract IDV award was issued by the VA National Acquisition Center to Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceuticals and medical products. The single-award, indefinite delivery contract has a ceiling value of $4,928,686.10 and a period of performance from February 13, 2023, to February 12, 2026, with the option to extend for four additional one-year periods. Under this contract, Golden State Medical Supply, Inc. will provide an...
The federal contract IDV award is for the supply of Cefpodoxime Proxetil Tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract was awarded to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The contract has a base period of one year from July 22, 2023 to July 21, 2024, with four one-year option periods, for a total potential...
The federal contract IDV award is for the supply of Solifenacin Succinate 10mg and 5mg tablets to the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The single-award, indefinite-delivery contract was issued by the VA National Acquisition Center to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor, for a period of performance from August 2020 to August 2025 with a ceiling value of $3,218,821.85. The contract...
The key elements of this federal contract IDV award are as follows: The Defense Logistics Agency (DLA) awarded an Indefinite Delivery Contract (IDC) to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The contract has a ceiling value of $6,883,760.65 and a period of performance through November 15, 2027. This single-award IDC is not designated as a set-aside. Under this IDC, Golden State Medical Supply has received...
The federal contract IDV award SPE2D221D0127 was granted to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The IDV has a ceiling value of $23,136,506.40 and was awarded on December 1, 2020 by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The IDV is designed to provide an uninterrupted supply of essential pharmaceutical products, including tablets and capsules for...
The federal contract IDV award is for the delivery of Carvedilol Tablets to support multiple federal agencies including the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract was awarded to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The contract has a base period of one year with four one-year option periods, for...
The federal contract IDV award is for the supply of approximately 115,000 bottles of 1200mg mesalamine tablets annually to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service. The prime contractor is Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceutical products, under its parent company Gsms Inc. The contract is a single-award, indefinite delivery contract with a ceiling value of...
The federal contract IDV award SPE2D223D0013 is a single-award Indefinite Delivery Contract valued at $3,988,286.45 and awarded to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The contract, which does not utilize any set-asides, was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) with an ultimate completion date of September 26, 2028. The contract is focused on providing a wide range...

The federal contract IDV award is for Loperamide HCL 2MG Capsules, with a single award made to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The contract was issued by the Department of Veterans Affairs (VA) National Acquisition Center and is not set aside for any specific business categories.

The contract has a base period of one year with four one-year option periods, and a ceiling value of $7,791,248.49. The contract aims to provide an uninterrupted supply of Loperamide HCL 2MG Capsules to multiple federal agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The capsules will be distributed through the VA and Department of Defense Pharmaceutical Prime Vendor Programs. The contract requires the successful offeror to use a unique label and National Drug Code (NDC) number for the product, which may impact competitive positioning for potential bidders.

Generated 7/17/25, 5:14 PM